ライフサイエンスコーパス: fmol

1 luminometer format, mixtures containing 1.0 fmol total luciferase were quantified from measurements

2 is 0.5 fmol/100 mug DNA, and the LOQ is 1.0 fmol/100 mug DNA, making it possible to quantify bis-N7G

3 umor lysates with a linear range of 0.05-2.0 fmol/mug of total lysate protein and with coefficients o

4 burgdorferi lipoprotein at the level of 4.0 fmol of ospA/mg of serum protein.

5 o 15.5 +/- 5.0, 12 +/- 3.0, and 10.0 +/- 4.0 fmol/mg of tissue, respectively.

6 ease of NE in CMA at 16 Hz from 27.8 +/- 6.0 fmol/mg of tissue to 15.5 +/- 5.0, 12 +/- 3.0, and 10.0

7 urinary bladder (1.8 +/- 0.5 and 9.0 +/- 6.0 fmol/mg of tissue, respectively), and murine urinary bla

8 Detection limits (3SD) of 1.6, 3.2, and 7.0 fmol estimated from three procedure blanks were obtained

9 umarate (TDF), and they remained above 1,000 fmol/10(6) cells for as long as 7 days.

10 e maximum number of binding sites was 23,000 fmol/mg.

11 earity of the fifth isotopologue (i.e., 0.05 fmol on column) was dependent on the peptide and instrum

12 sible signals for RNA amounts as low as 0.05 fmol.

13 run time (4 min), limit of detection (0.055 fmol on column, 18.75 fmol/ml plasma), precision (relati

14 tes of DNA methylation down to 0.34 +/- 0.06 fmol/s.

15 etection of melamine and Sudan I down to 0.1 fmol in water and toluene, respectively, using just 1 mu

16 in DNA samples with a detection limit of 0.1 fmol.

17 d be detected at a concentration down to 1.1 fmol L(-1).

18 n, achieving a detection limit of 55 pM (1.1 fmol), and the combined competitive-amplification latera

19 3.3 nM (+/-0.58), and receptor density, 10.1 fmol/mg (+/-0.64), was obtained with a saturation bindin

20 case, the sensitivity of the MS was about 1 fmol, which allowed us to achieve a spatial resolution o

21 s with concentrations down to 1 microM and 1 fmol of protein nondestructively probed within the excit

22 ed with a detection limit of approximately 1 fmol/pixel from a variety of MALDI matrixes.

23 of the active form of MMP-12 to be around 1 fmol/mul in BALf from nanoparticle-treated mice.

24 assays with limits of detection as low as 1 fmol/L target DNA.

25 hat promotes cowpea ethylene production at 1 fmol leaf(-1) and triggers increases in the defense-rela

26 er assay (1 nM) and dynamic ranges between 1 fmol and at least 750 fmol (1-750 nM) were obtained.

27 Sample loadings ranging from 1 fmol to 10 pmol/spot were investigated.

28 and a quantification linearity range from 1 fmol to 20 pmol.

29 sulfate reduction rates are low enough (<<1 fmol H2Scell(-1)d(-1)).

30 4 fmol/muL), and sensitive (LLOD and LLOQ <1 fmol/muL).

31 Direct visualization of 1 fmol of target DNA molecules of interest was demonstrate

32 Limits of detection of 1 fmol per assay (1 nM) and dynamic ranges between 1 fmol

33 the optimized assay, a detection limit of 1 fmol was obtained.

34 tive form of MMP-12 down to a threshold of 1 fmol.

35 tings allows rapid enrichment from 5 mL of 1 fmol/muL phosphoprotein digests and concentration into s

36 When only 1 fmol of BSA was injected, one BSA peptide was consistent

37 ables complete Sanger sequencing from only 1 fmol of DNA template.

38 was demonstrated at the level of less than 1 fmol of the peptide consumed.

39 hophora cells at rates between 0.02 and 0.10 fmol h(-1) cell(-1) and down to extracellular concentrat

40 tivity for epsilon-ADPR was approximately 10 fmol.

41 This assay can reach a detection limit of 10 fmol and an isolation rate of 90% for the antigen CFP-10

42 rm also displayed a limit of detection of 10 fmol for thrombin in five different human serum samples

43 as achieved, with a limit of detection of 10 fmol/mL (0.64 ng/mL).

44 ents had AGT activity levels of less than 10 fmol/mg protein with a continuous-infusion O6-BG dose of

45 for concentrations of peptides lower than 10 fmol/microL, is to wash matrix/sample spots after peptid

46 fied in this work ranged from 110 pmol to 10 fmol per milligram of tissue protein.

47 The limit of detection for thrombin was 10 fmol in buffer using the aptamer/ISET-MALDI-MS configura

48 g detection limit for the full method was 10 fmol/mL (0.6 ng/mL).

49 The 1-10-fmol sensitivity and linear dynamic range allows quantit

50 Microinjection of BDNF (10-100 fmol) into the RVM facilitates nociception, which is dep

51 a high density of AT(1) binding (1207+/-100 fmol/g), which peaked at 0.4 mm rostral to the calamus s

52 allows a detection limit between 30 and 100 fmol DNA with a macroscopic gold disc electrode of 1 mm

53 y high loading capacities, approximately 100 fmol for angiotensin I and approximately 50 fmol for ins

54 nts resulted in sensitivities as high as 100 fmol of glycoprotein and 0.1 muL of human blood serum.

55 the sample, was detectable at less than 100 fmol using EDTA-2D-RP/RP-nanoUPLC-MS/MS.

56 f spiked melamine in liquid milk down to 100 fmol also highlights the suitability of our SHP-OP SERS

57 of RNase B was fully characterized using 100 fmol of tryptic digest on a three-dimensional ion trap m

58 es and steroids down to the 800-amol and 100-fmol levels, respectively.

59 er incubation and that levels as low as 0.11 fmol of TPP per cell could be detected, suggesting the h

60 in those four ganglia are 481, 45, 9, and 11 fmol/mg protein, respectively.

61 5)I-labeled NmU (K(D) 364 pM and B(max) 1114 fmol/mg protein) was identified, and mRNA encoding NmU-1

62 - 18.0 nM and maximal binding of 348 +/- 112 fmol/mm(2)) to rat kidney AT1R.

63 increases in basal ECF ACh (from 105 to 118 fmol/min) and in the increase produced by atropine (from

64 ng agent, ionizing linearly from 150 to 1200 fmol (on-target) with a mean CV of 7%.

65 ion per zone loaded for fluorescence was 125 fmol for fluorescein isothiocyanate-labeled bovine serum

66 LOD for the above targets were 22.1 and 1260 fmol, respectively.

67 cal hyperinsulinemia (15 +/- 3 and 87 +/- 13 fmol x min(-1) x 100 ml(-1) basal vs. last 40 min of cla

68 ds to a detection limit of approximately 130 fmol of Intimin-ECD.

69 Adduct levels ranged from 0.43 to 131 fmol platinum/microg DNA in 140 samples; and adducts wer

70 f 3.7, 3.9, and 4.8% for 1.66, 6.65, and 133 fmol on column), and accuracy (97.5-104.5%).

71 ar over the range 0.23 to 19 nM (1.66 to 133 fmol on column).

72 compared with control subjects (166 vs. 133 fmol/ml, p=0.0003).

73 inear over a wide range (r > 0.99, 0.01-1384 fmol/muL), and sensitive (LLOD and LLOQ <1 fmol/muL).

74 mits of detection were determined to be 0.14 fmol for phenanthrene and 4 amol for caffeine and to a p

75 % (57.23 fmol/muL) of the total H3 HA (61.14 fmol/muL) in purified virus.

76 lumn limits of detection between 0.55 and 15 fmol.

77 A brushes allow detection of as little as 15 fmol of phosphopeptide.

78 to over 3 mM (0.15 pmol) and 500 microM (15 fmol) for fluorescein and TRITC-tagged albumin solutions

79 (358 fmol) and protein (ranging from 7 to 15 fmol depending on the assayed protein).

80 to 44.8 nmol x person(-1) x min(-1) (16-1530 fmol x cm(-2) x min(-1)).

81 20% calcium diet had renal VDR levels of 165 fmol/mg protein.

82 t of 2 nM and maximum binding capacity of 18 fmol/10(6) cells, and (18)F-FES had a dissociation const

83 ol vs. +AnxA4: 1956 +/- 162 vs. 1304 +/- 185 fmol/microg protein; n = 8).

84 tomole range with a limit of detection of 19 fmol.

85 alysates rose from 73 fmol/min to 148 or 197 fmol/min (P<0.05).

86 itive with a limit of detection (LOD) of 0.2 fmol and a quantification linearity range from 1 fmol to

87 absolute quantification of as little as 0.2 fmol of miR-203.

88 loped a simple, sensitive (approximately 0.2 fmol on column) and specific GC-MS assay for the detecti

89 crol of liquid is required, as little as 1.2 fmol of trypsin can be detected by using the on-chip ass

90 The limit of detection was 11.2 fmol injected on-column, and the limit of quantitation w

91 7.1 +/- 0.7, 26.5 +/- 4.5, and 15.1 +/- 3.2 fmol/mg of tissue, respectively.

92 A detection limit (3 SD) of 7.2 fmol estimated for ID LC-ICPMS with a 10 muL injection v

93 wells, the limit of detection (LOD) was 7.2 fmol of DNA target, corresponding to a final concentrati

94 peptidases (degradation rate of 100 +/- 8.2 fmol min(-1) mg(-1)) but an excellent substrate for phos

95 ction for phosphopeptides is approximately 2 fmol, based on using matrix-assisted laser desorption/io

96 of single cell with sensitivity as low as 2 fmol.

97 agnitude, and a detection limit for IgG of 2 fmol.

98 des were detected in a mixture containing 20 fmol of human growth hormone tryptic digest mixed with t

99 and 14 peptide identifications (IDs) when 20 fmol was loaded.

100 rays, a 2-D DNA array is used to detect a 20-fmol sample of in vitro transcribed RNA from the uidA ge

101 were calculated to be approximately 0.4 (200 fmol) and 0.8 microM (400 fmol), respectively.

102 ntified for standard I by consuming only 200 fmol of each protein.

103 ulted in an increased dynamic range (15-2000 fmol on plate) and improved linearity (r(2) = 0.99).

104 ressed at similar levels (approximately 2000 fmol/mg) and bound the radioligand [(3)H]R(+)-7-chloro-8

105 32 smoker samples (mean +/- SD, 179 +/- 205 fmol/micromol dAdo).

106 issue)(-1)) relative to controls (234 +/- 21 fmol (mg tissue)(-1)), and sepiapterin elevated flow-med

107 erved for Arg-389 (435 +/- 80 vs. 115 +/- 23 fmol per well).

108 n control animals, NET B(max) was 388 +/- 23 fmol/mg protein and HED heart uptake (HU) at 30 min was

109 uL) from the commercial TIV and 93.6% (57.23 fmol/muL) of the total H3 HA (61.14 fmol/muL) in purifie

110 detection limit was of 12.0 nmol L(-1) (240 fmol in the sample).

111 hput assay for ACK1 capable of detecting 240 fmol per well of the kinase reaction product employing a

112 A low detection limit of 240 fmol in 2 mL of SSC buffer was achieved.

113 nM) and receptor concentration (296 vs. 243 fmol/mg).

114 ic small RNA was detected in amounts of 0.25 fmol (i.e. concentration of 10 pM in a 25 microl reactio

115 (1:3500) and limit of detection down to 0.25 fmol.

116 o 66 kDa) with a detection limit of 8 and 25 fmol for verapamil and reserpine, respectively, and quan

117 We were able to detect 25 fmol of Rhodamine in agar ablation experiments.

118 imit (signal/noise ratio of 3) of 0.5 nM (25 fmol on column).

119 on of 5 nM solution containing a total of 25 fmol labeled analyte.

120 Injection of 25 fmol of [Glu1]-fibrinopeptide B using the new device pro

121 to 250 pmol, with a limit of detection of 25 fmol on column for all analytes except 2-AG, noladin eth

122 Linearity was proven over the range of 25 fmol to 250 pmol, with a limit of detection of 25 fmol o

123 osylation structures, was obtained at the 25 fmol level.

124 trols (mean [SD], 0.70 [0.33] vs 1.93 [1.25] fmol/mg, respectively; P = .001).

125 accumulation at a rate of approximately 250 fmol/min/cm2, reflecting the basal ATP release rate.

126 he method is able to detect as little as 250 fmol of target without using PCR and exhibits single nuc

127 es except 2-AG, noladin ether, and 2-LG (250 fmol).

128 ep with purified H3 HA captured 82.9% (55.26 fmol/muL) of the total H3 HA (66.69 fmol/muL) from the c

129 t of detection (LOD) of 4.7 ppm (for only 26 fmol H2).

130 (with a K(D) of 2.97 nM and a B(max) of 2619 fmol/mg protein).

131 tection limit of 0.14 nM corresponding to 28 fmol of analyte.

132 ted BK 1-5 (160 +/- 75 fmol/mL, vs 44 +/- 29 fmol/mL in controls) and angiotensin II (182 +/- 41 pg/m

133 e units or 500 nM bromophenol blue (BPB) (29 fmol) was achieved using only an optical microscope and

134 and binding data reports low NOP density (29 fmol mg(-1) protein) in dog.

135 ass IV patients as determined by POCTs (>290 fmol/ml) nano-LC-electrospray ionization-FT-ICR-MS data

136 es from immature MDDCs yielded B(max) of 298 fmol/mg of protein and K(D) of 0.7 nM.

137 I increased cGMP accumulation by 4.9 +/- 1.3 fmol/microg (p < 0.01).

138 re the rate of in vitro RNA synthesis (~10.3 fmol of RNA per minute).

139 se-derived sphingosine-NDA were 9.6 and 12.3 fmol, respectively, and the limits of quantification wer

140 d peptide with a method detection limit of 3 fmol.

141 e as evidenced by the detection of 100 pg (3 fmol) of a test protein spiked into 1 microg of a comple

142 endogenous beta(2)AR in HEK293 cells (20-30 fmol/mg) caused a rapid and transient activation of ERK1

143 approximately 300 pM of DNA target, i.e. 30 fmol in a 100 muL sample) and excellent selectivity, all

144 n caused renal VDR levels to decrease to <30 fmol/mg protein in vitamin D-deficient mice and to appro

145 method, and a detection limit of 600 nM (30 fmol) was determined.

146 scope detection platform offered a LOD of 30 fmol and a dynamic range spanning 3 orders of magnitude.

147 ) hepatocytes, but reaches a limit at 90-300 fmol.

148 f detection of the assay was found to be 300 fmol with the upper limit of the dynamic range at 5 pmol

149 IL and was nontoxic at doses ranging from 32 fmol/kg to 3.2 pmol/kg.

150 n full scan mode, detection limits of 0.1-33 fmol were achieved for glycoloytic and tricarboxylic aci

151 ent Michaelis-Menten parameters of Vm = 0.34 fmol/s and kcat/Km on the order of 104 s-1 M-1, in agree

152 the limit of detection of the method was 34 fmol, which is a significant improvement in comparison t

153 . anxA4a(-/-): 1891 +/- 238 vs. 2796 +/- 343 fmol/microg protein; n = 9-10).

154 aried from below the limit of detection (350 fmol/g) to 15 pmol/g wet brain.

155 direct measurement of sulfur with ICPMS (358 fmol) and protein (ranging from 7 to 15 fmol depending o

156 The results provide a detection limit of 36 fmol for step-scan SIR measurements of ferrocyanide.

157 covery of 90% and a limit of detection of 38 fmol per single spot sampled.

158 lume of 50 microL, corresponding to only 380 fmol (3.97 ng) of the rK5 analyte being injected onto th

159 increased ACh concentrations from 81 to 386 fmol/min in control rats and from 137 to 680 fmol/min in

160 ly reduced renal VDR levels, from 555 to 394 fmol/mg protein (29%, P < 0.001).

161 er investigators (15 x 10-4 versus 34 x 10-4 fmol/cell in HbAA versus HbSS erythrocytes).

162 amounts of total labile iron (1.6-1.8 x 10-4 fmol/cell) or hemoglobin iron (18 000-19 000 x 10-4 fmol

163 ll) or hemoglobin iron (18 000-19 000 x 10-4 fmol/cell).

164 AA cells (0.0016 x 10-4 versus 0.0004 x 10-4 fmol/cell; P =.01), but much lower than the mean amounts

165 with K(d) of 3.64 nmol/L and B(max) of 120.4 fmol per million cells.

166 asma brain natriuretic peptide levels (-19.4 fmol x ml(-1); 95% CI, -5, -34; p = 0.014) and improveme

167 urinary bladder (1.4 +/- 0.1 and 6.2 +/- 2.4 fmol/mg of tissue, respectively).

168 1.6 +/- 27.4 versus LP n = 7, 445.7 +/- 27.4 fmol (mg glomerular protein)(-1), P < 0.01), but affinit

169 fication of FodU at a detection limit of 3-4 fmol, which is approximately 20-fold better than that fo

170 were between 0.04 to 0.5 nmol/L (0.2 to 3.4 fmol) at a signal-to-noise ratio of 3.

171 lso improved dramatically using SPE (8 and 4 fmol/ml) compared with organic extraction (25 and 18.75

172 e than those grown aerobically (1.3 x 10(-4) fmol/cell vs 7.9 x 10(-6) fmol/cell; P < 0.01).

173 ssay was validated in a linear range from 40 fmol to 200 pmol 5mdC.

174 The molecular weight determination of 40 fmol/microL apomyoglobin was determined in 3 s using a r

175 oximately 0.4 (200 fmol) and 0.8 microM (400 fmol), respectively.

176 cids were measured and ranged from 30 to 400 fmol islet(-1) min(-1).

177 ol subjects (181 +/- 7 fmol/g vs. 262 +/- 41 fmol/g; p < 0.05).

178 ith a maximum binding capacity (Bmax) of 414 fmol/10(6) cells (2.5 x 10(5) GRP-R/cell).

179 EAS-2B cells occurred at a median rate of 43 fmol min(-1) mg(-1) resulting in a mean half-life of 20

180 CV) of 5%, and a quantification limit of 432 fmol.

181 8 h reduced renal VDR levels from 515 to 435 fmol/mg protein (15%, P < 0.03) in wild-type mice.

182 OD of the assay in a sandwich format was 450 fmol with a dynamic range spanning 2 orders of magnitude

183 microM) for penicillin and ampicillin to 455 fmol (350 microM) for histidine were obtained.

184 1 min with detection limits of 0.54 and 1.47 fmol for 5mdC and 2dG, respectively.

185 ion limit was determined to be as low as 0.5 fmol in 80 microg DNA, corresponding to 9 adducts/10(9)

186 copic responses being derived from just ~0.5 fmol of material.

187 pable of reliably detecting as little as 0.5 fmol of protein, and protein differences down to +/- 15%

188 gnitude across the gradient (500 fmol to 0.5 fmol on column) and no systematic trend was observed for

189 Detection limits as low as 0.5 fmol were obtained, with lower possible if a smaller sam

190 The LOD value of the new method is 0.5 fmol/100 mug DNA, and the LOQ is 1.0 fmol/100 mug DNA, m

191 race peptides at levels of approximately 0.5 fmol/microL in complex peptide mixtures with a wide dyna

192 tained in 10 mug of DNA hydrolysates was 1.5 fmol, which corresponded to 50 adducts/10(9) normal nucl

193 e allowed for the sensitive detection of 2.5 fmol of methylated target dsDNA in 5 min.

194 easurement of high quality IR spectra of 2.5 fmol of molecules confined to a 125 mum(2) beam spot.

195 ximately 50 pM in 50 muL ( approximately 2.5 fmol).

196 for SMN1 and uidA target were 54.3 and 30.5 fmol, and when the probe ratio was 4:1, the LOD for the

197 grees C of calculated temperature over a 5.5 fmol.cell(-1).d(-1) increase in varphi.

198 in was detected with an LOD of 300 nM or 7.5 fmol injected.

199 imits of detection of 3.6, 1.6, 5.8, and 8.5 fmol for estradiol, androstendione, testoterone, and pro

200 observed with TM-AFM and CV coincide (2-8.5 fmol.cm(-)(2)), indicating that most-if not all-cbo(3) o

201 he PB/AChE-ChO electrode was 5 microM or 9.5 fmol.

202 test compound, 1.6 pmol of substrate, and 5 fmol of enzyme per reaction.

203 tely 10% (relative standard deviation) and 5 fmol on-column, respectively.

204 on spectra were obtained with as little as 5 fmol of peptides.

205 As few as 5 fmol of VEGF(165) could be detected by the naked eye wit

206 The detection limit is 5 fmol for the synthetic single-stranded DNA.

207 analytes and with high sensitivity (LOD of 5 fmol for caffeine).

208 -8) M, consumes very little sample (< or = 5 fmol), and offers capillary interfaces with various sepa

209 d the limits of detection to be in the 2.5-5-fmol range.

210 cases (mean [SD], 16.2 [2.0] vs 29.6 [16.5] fmol/mg, respectively; P = .04) or with male and female

211 fmol for angiotensin I and approximately 50 fmol for insulin, were obtained with a 4.2 m x 10-microm

212 ected with a lower limit of approximately 50 fmol of complement and was sufficiently selective to dif

213 nrichment with sensitivity assessed to be 50 fmol.

214 A detection limit of 50 fmol M(1)GdR/ml urine is achieved starting with 5 ml of

215 ntitative assay with a detection limit of 50 fmol of target DNA.

216 However, it was found that with less than 50 fmol of biotin-labeled nucleic acid, which corresponds t

217 apable of reliable detection of less than 50 fmol of the derivatives of S1P and DHS1P without signifi

218 ut a measurement is very small, less than 50 fmol, which would be a useful attribute for drug screeni

219 ial samples were easily detected, down to 50 fmol on column.

220 greater than 20,000 pg/mg creatinine (12,500 fmol/mg) between postnatal days 1-4 occurred among 54% o

221 of detection of the setup (approximately 500 fmol limit of detection for citric acid), improvements i

222 with concentrations at 3 days exceeding 500 fmol/10(6) mononuclear cells.

223 orders of magnitude across the gradient (500 fmol to 0.5 fmol on column) and no systematic trend was

224 for the total ion current peak areas of 500 fmol of angiotensin I were improved by a factor of 2.6 w

225 Bilateral NTS microinjection of SP (500 fmol) produced a similar selective attenuation of the ca

226 ng platform allowed for detection down to 53 fmol of Streptococcus pneumoniae tmRNA, equivalent to ap

227 ch prostaglandin was 20 pg/ml (0.20 pg, 0.55 fmol on-column), and the interday and intraday coefficie

228 a limit of quantification at lower than 0.56 fmol/muL.

229 crease produced by atropine (from 489 to 560 fmol/min; P<0.05).

230 (9.3 +/- 0.6, 10.1 +/- 0.5 and 10.3 +/- 0.6 fmol mg(-1) protein, respectively), but there were no so

231 vs. anxA4a(-/-): 5.1 +/- 0.3 vs. 6.7 +/- 0.6 fmol/microg protein) or FSK (anxA4a(+/+) vs. anxA4a(-/-)

232 in the samples collected before EFS (0.2-1.6 fmol/mg of tissue).

233 on of FD&C Red #3, which corresponded to 2.6 fmol of analyte in the 150-pL detection volume.

234 n for dopamine and catechol were 1.7 and 2.6 fmol, respectively (S/N = 3).

235 on-column, equivalent to 8 pg/mL (26.5-29.6 fmol/mL) in the original serum sample.

236 detection limits ever published (11 and 6.6 fmol, respectively).

237 Detection limits ranging from 6 fmol (5 microM) for penicillin and ampicillin to 455 fmo

238 ally (1.3 x 10(-4) fmol/cell vs 7.9 x 10(-6) fmol/cell; P < 0.01).

239 Injection of 60 fmol of gamma-MSH into the lateral cerebral ventricle of

240 model system, and a limit of detection of 62 fmol is achieved.

241 one AF and control subjects (1,730 vs. 1,625 fmol/ml, p=0.90).

242 ties of AT(1) binding, 278+/-38 and 379+/-64 fmol/g, respectively.

243 tion limits of detection were as low as 1.65 fmol.

244 43; NF LV, 32.89+/-5.38; NF RV 40.49+/-10.66 fmol/min per milligram (P<0.05 PPH RV versus PPH LV; P<0

245 found that human lung macrophages contain 66 fmol of this protein per 100 microg of cell protein.

246 fmol/min in control rats and from 137 to 680 fmol/min in those consuming UMP (P<0.05).

247 % (55.26 fmol/muL) of the total H3 HA (66.69 fmol/muL) from the commercial TIV and 93.6% (57.23 fmol/

248 but increased in control subjects (181 +/- 7 fmol/g vs. 262 +/- 41 fmol/g; p < 0.05).

249 limits of quantification were 34.2 and 45.7 fmol, respectively.

250 As little as 70 fmol glycan species can be detected and identified.

251 h a high degree of anti-HIV protection (>700 fmol/punch) were found in 42 (54%), 37 (47%), 38 (49%),

252 h levels in striatal dialysates rose from 73 fmol/min to 148 or 197 fmol/min (P<0.05).

253 R(-/-) mice have elevated BK 1-5 (160 +/- 75 fmol/mL, vs 44 +/- 29 fmol/mL in controls) and angiotens

254 it of detection (0.055 fmol on column, 18.75 fmol/ml plasma), precision (relative standard deviations

255 mpared with organic extraction (25 and 18.75 fmol/ml plasma).

256 namic ranges between 1 fmol and at least 750 fmol (1-750 nM) were obtained.

257 57 versus 1001 +/- 31 or versus 1315 +/- 76 fmol/nmol/h, P <.0001).

258 ith a detection limit of 1.3 ng/ml (i.e. 0.8 fmol in used sample volume of 10 microl).

259 12.9 +/- 0.9, 13.5 +/- 0.9 and 13.6 +/- 0.8 fmol mg(-1) protein, respectively) and Arg16+Gln27 havin

260 ring EFS of CMA (2.5 +/- 0.9 and 5.8 +/- 0.8 fmol/mg of tissue, respectively), canine urinary bladder

261 highest in the amygdala (B(max)=149.9+/-13.8 fmol/mg protein), thalamic, and hypothalamic nuclei.

262 lumn, and the limit of quantitation was 22.8 fmol.

263 nly 7 of 30 nonsmoker samples (15.5 +/- 33.8 fmol/micromol dAdo; P < 0.001).

264 numbers in both the stimulated (35.2 +/- 4.8 fmol acetylcholine receptor/mg protein) and nonstimulate

265 lower in arterioles from old rats (94 +/- 8 fmol (mg tissue)(-1)) relative to controls (234 +/- 21 f

266 ers of magnitude with a detection limit of 8 fmol of toxin is achieved.

267 le controls combined (mean [SD], 53.9 [19.8] fmol/mg; P = .005).

268 tection of LD/LI/ToF-MS as low as [0.2, 2.8] fmol per laser pulse and we make quantitative prediction

269 ) = 7.62 +/- 1.18 nM, B(max) = 31.6 +/- 1.80 fmol/mg protein) that is distinct from fatty acid amide

270 min D-deficient mice and to approximately 80 fmol/mg protein in vitamin D-replete mice.

271 al release of UDP-glucose and ATP (72 and 81 fmol/min/10(6) cells) combined with a rate of UDP-glucos

272 tly showed high TFV-DP levels (median, 1,810 fmol/10(6) cells) between 4 and 24 h that exceed the 95%

273 5 nM) specifically bound to B-CK (2330+/-815 fmol mg protein(-1)).

274 tant of 3 nM and maximum binding capacity 83 fmol/10(6) SKOV3 cells.

275 ates can be measured as low as 3.55 +/- 1.84 fmols(-1) in a 96-well plate format, and the assay has b

276 oxylation (K(m) = 812.3 nm and V(max) 47.85 (fmol/min/pmol P450)).

277 e concentration(50) values of 68, 45, and 87 fmol leaf(-1) for Vu-In, Vu-(E+)In, and Vu-(GE+)In, resp

278 initial reaction rates averaged 3.9 +/- 2.9 fmol AngII/min/ micro g protein with a mean maximal conv

279 4.7, and 1.93 ng/mg HSA (1010, 220, and 28.9 fmol BPDE equiv/mg HSA)--were significantly different (P

280 endothelin-1 (80 +/- 15.7 versus 29 +/- 3.9 fmol/kg body wt per d; P < 0.02) and of the NO metabolit

281 the series (intrathecal ED50 approximately 9 fmol per mouse), whereas in untreated mice its ED50 was

282 obtained in the concentration range of 10-90 fmol/microL.

283 r format provided a limit of detection of 90 fmol and an upper limit of dynamic range of 3.5 pmol.

284 ut still significant increase (from 75 to 92 fmol/min, P<0.05), and elevated striatal ACh content (by

285 of GSH in HepG2 cells to be 14.96 muM (2.99 fmol/cell).

286 l-D-glucose uptake into erythrocytes was 996 fmol/10(6) red blood cells per second, significantly les

287 ective detection of the peptide biosensor at fmol levels from aliquots of cell lysate equivalent to ~

288 oteinase inhibitor proteins when supplied at fmol levels to young tomato plants through their cut ste

289 species involved in the redox process (e.g., fmol/cm(2), 0.1% of a full protein monolayer).

290 f unique, long oligonucleotides (150mers) in fmol amounts using parallel synthesis of DNA on microarr

291 es can be simultaneously quantified from low fmol/muL to nmol/muL levels in cellular samples.

292 marked increase in analytic sensitivity (low fmol/muL) and the identification of double bond position

293 markedly increases analytic sensitivity (low fmol/muL).

294 aterial and has a detection limit in the low fmol range, and is thus the most sensitive method for di

295 ompounds with limit of detection down to low fmol levels, capability of analyzing small and large mol

296 ibody bead, (ii). detecting peptides at low (fmol) levels, (iii). producing MS/MS data of suitable qu

297 y (maximum number of binding sites [B(max)], fmol/mg protein) for each heart.

298 d and chemotherapy-resistant BPL at nontoxic fmol/kg dose levels.

299 urces and lowest sample amount requirements (fmol range).

300 trochemical stripping transduction (to yield fmol detection limits) and with an efficient magnetic se